Skip to main content
OpenTrials

Clinical trial condition

Retinal Vein Occlusion

Explore clinical trials studying Retinal Vein Occlusion. Study availability and eligibility vary by location and protocol.

188 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Retinal Vein Occlusion trial results

Completed

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab

NCT01471691

Conditions
Branch Retinal Vein Occlusion, Cardiovascular Diseases, Central Retinal Vein Occlusion, +10 more
Locations
  • South Coast Retina Huntington Beach, California, United States
  • South Coast Retina Long Beach, California, United States
  • Thomas Hanscom AMC Santa Monica, California, United States
  • South Coast Retina Torrance, California, United States
View Trial Details
Completed

Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)

NCT01521559

Conditions
Branch Retinal Vein Occlusion, Cardiovascular Diseases, Embolism and Thrombosis, +6 more
Locations
  • Phoenix, Arizona, United States
  • Tucson, Arizona, United States
  • Beverly Hills, California, United States
  • La Jolla, California, United States
View all 56 locations
View Trial Details
Completed

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

NCT01396057

Conditions
Branch Retinal Vein Occlusion, Cardiovascular Diseases, Embolism and Thrombosis, +16 more
Locations
  • Novartis Investigative Site Prague, Czechia
  • Novartis Investigative Site Leipzig, Germany
  • Novartis Investigative Site Regensburg, Germany
  • Novartis Investigative Site Augsburg, Germany
View all 66 locations
View Trial Details

Related conditions